Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial.

MLA

Welsh, Paul, et al. “Do Cardiac Biomarkers NT-ProBNP and HsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial.” Diabetes Care, vol. 37, no. 8, Aug. 2014, pp. 2202–10. EBSCOhost, https://doi.org/10.2337/dc13-2625.

APA

Welsh, P., Woodward, M., Hillis, G. S., Qiang Li, Marre, M., Williams, B., Poulter, N., Ryan, L., Harrap, S., Patel, A., Chalmers, J., & Sattar, N. (2014). Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial. Diabetes Care, 37(8), 2202–2210. https://doi.org/10.2337/dc13-2625

Chicago

Welsh, Paul, Mark Woodward, Graham S. Hillis, Qiang Li, Michel Marre, Bryan Williams, Neil Poulter, et al. 2014. “Do Cardiac Biomarkers NT-ProBNP and HsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial.” Diabetes Care 37 (8): 2202–10. doi:10.2337/dc13-2625.